Crossmark

The relationship between pan-immune-inflammation value and survival outcomes in patients with metastatic renal cell carcinoma treated with nivolumab in the second line and beyond: a Turkish oncology group kidney cancer consortium (TKCC) study

Crossref DOI link: https://doi.org/10.1007/s00432-022-04055-5

Published Online: 2022-05-26

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yekedüz, Emre

Tural, Deniz

Ertürk, İsmail

Karakaya, Serdar

Erol, Cihan

Ercelep, Özlem

Arslan, Çağatay

Sever, Özlem Nuray

Kılıçkap, Saadettin

Şentürk Öztaş, Nihan

Küçükarda, Ahmet

Can, Orçun

Öksüzoğlu, Berna

Şendur, Mehmet Ali

Karadurmuş, Nuri

Ürün, Yüksel https://orcid.org/0000-0002-9152-9887
License Information

Text and Data Mining valid from 2022-05-26

Version of Record valid from 2022-05-26
More Information

Article History

Received: 27 March 2022

Accepted: 3 May 2022

First Online: 26 May 2022

Declarations

:

: The authors have no relevant financial or non-financial interests to disclose.

Document is current

Any future updates will be listed below